Determinants of survival in triple-negative breast cancer: A clinicopathological study from an Indonesian Cancer Center
A BSTRACT Triple-negative breast cancer (TNBC) outcomes in Southeast Asian and resource-limited settings remain underreported. This study evaluated factors associated with 3-year overall survival (OS), event-free survival (EFS) in stage I–IIIC disease, and progression-free survival (PFS) in stage IV disease....